Literature DB >> 12691146

High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.

Sabine L A Plasschaert1, Edo Vellenga, Eveline S J M de Bont, Dorina M van der Kolk, Anjo J P Veerman, Wim J Sluiter, Simon M G Daenen, Elisabeth G E de Vries, Willem A Kamps.   

Abstract

There is a distinct difference in prognosis between childhood versus adult acute lymphoblastic leukaemia (ALL). To define whether multidrug resistance (MDR) genes might contribute to this distinction, the expression and functional activity of P-glycoprotein (P-gp) and MDR associated proteins (MRP) were determined with RT-PCR (MDR-1, MRP1, MRP2, MRP3) and flow cytometry (P-gp and MRP). Patient samples were obtained from 36 children and 35 adults with de novo ALL. Of these patients, 38 showed a T-lineage and 33 showed a B-lineage immunophenotype. In the samples, large variability in P-gp activity (0.8-4.9) and MRP activity (1.1-13.9) was observed. Most T-ALL patients with high P-gp activity were adults (89%). The mRNA expression of MDR-1 correlated weakly with P-gp activity. In contrast, MRP activity did not correlate with the mRNA expression of MRP1, MRP2 and MRP3. In T-ALL, a worse overall survival and event-free survival was observed with increasing P-gp activity. P-gp activity had no prognostic impact in B-lineage ALL. In addition, high MRP activity did not influence treatment outcome in either T- or B-lineage ALL. Multivariate Cox regression analysis, showed P-gp activity to be the only unfavourable prognostic factor for overall survival in T-ALL. In conclusion, this study demonstrates the prognostic relevance of P-gp activity in T-ALL. Since the majority of the patients with high P-gp activity were adults, P-gp might contribute to the poor prognosis of adult T-ALL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691146     DOI: 10.1080/1042819021000040288

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

Authors:  Jan Styczynski; Mariusz Wysocki; Robert Debski; Krzysztof Czyzewski; Beata Kolodziej; Beata Rafinska; Malgorzata Kubicka; Sylwia Koltan; Andrzej Koltan; Monika Pogorzala; Andrzej Kurylak; Dorota Olszewska-Slonina; Walentyna Balwierz; Edyta Juraszewska; Maria Wieczorek; Igor Olejnik; Maryna Krawczuk-Rybak; Marta Kuzmicz; Jerzy Kowalczyk; Jolanta Stefaniak; Wanda Badowska; Danuta Sonta-Jakimczyk; Tomasz Szczepanski; Michal Matysiak; Iwona Malinowska; Elzbieta Stanczak; Jacek Wachowiak; Benigna Konatkowska; Lidia Gil; Anna Balcerska; Lucyna Maciejka-Kapuscinska
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

2.  ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia.

Authors:  Stuart S Winter; Jerec Ricci; Li Luo; Debbie M Lovato; Hadya M Khawaja; Tasha Serna-Gallegos; Natalie Debassige; Richard S Larson
Journal:  Health (Irvine Calif)       Date:  2013-05

3.  Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11).

Authors:  Susan J Zunino; David H Storms; Jonathan M Ducore
Journal:  Cancer Lett       Date:  2010-04-09       Impact factor: 8.679

4.  Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

Authors:  Keith W Crawford; John Spritzler; Robert C Kalayjian; Teresa Parsons; Alan Landay; Richard Pollard; Vicki Stocker; Michael M Lederman; Charles Flexner
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

5.  Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

Authors:  M Kourti; N Vavatsi; N Gombakis; V Sidi; G Tzimagiorgis; T Papageorgiou; D Koliouskas; F Athanassiadou
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

6.  mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.

Authors:  Soheila Rahgozar; Alireza Moafi; Marjan Abedi; Mansureh Entezar-E-Ghaem; Jamal Moshtaghian; Kamran Ghaedi; Abolghasem Esmaeili; Fatemeh Montazeri
Journal:  Cancer Biol Ther       Date:  2013-10-21       Impact factor: 4.742

7.  Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.

Authors:  Manman Deng; Jie Zha; Zhiwu Jiang; Xian Jia; Yuanfei Shi; Peng Li; Xiao Lei Chen; Zhihong Fang; Zhiqiang Du; Bing Xu
Journal:  J Transl Med       Date:  2018-02-28       Impact factor: 5.531

8.  Pattern of ABCC Transporter Gene Expression in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia.

Authors:  Narjes Mehrvar; Hassan Abolghasemi; Mohammad Reza Rezvany; Mohammad Esmaeil Akbari; Javad Saberynejad; Azim Mehrvar; Mohammad Ali Ehsani; Mahyar Nourian; Ibrahim Qaddoumi; Abolfazl Movafagh
Journal:  Rep Biochem Mol Biol       Date:  2019-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.